Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Buys VelQuest for $35M

NEW YORK (GenomeWeb News) – Accelrys today announced the $35 million all-cash acquisition of VelQuest in a deal that extends the San Diego-based company's capabilities beyond research into the quality assurance and quality control phases of product development.

VelQuest, based in Hopkinton, Mass., provides paperless laboratory execution systems that support current Good Manufacturing Practices for US Food and Drug Administration-regulated industries, including pharmaceutical and biotechnology firms. The acquisition is expected to offer significant productivity improvements, faster cycle times, more inexpensive operation costs, and reduced compliance risks for regulated life sciences organizations, Accelrys said.

Some of VelQuest's offerings have been integrated with Acclerys' solutions, and the purchase creates an opportunity to move VelQuest products beyond the life sciences by leveraging Accelrys' existing market presence and relationships with customers in other industries, according to an Accelrys statement.

Key members of VelQuest's management team also will move to Accelrys.

Accelrys expects the deal to be slightly dilutive to full-year 2012 non-GAAP net income per share, it said.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.